Elite Pharmaceuticals, Inc.
ELTP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $27 | $22 | $11 | $8 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $41 | $36 | $29 | $18 |
| Inventory | $18 | $19 | $16 | $20 |
| Other Curr. Assets | $0 | $1 | $1 | $1 |
| Total Curr. Assets | $86 | $78 | $58 | $48 |
| Property Plant & Equip (Net) | $13 | $14 | $14 | $14 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $6 | $6 | $6 | $7 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $12 | $13 | $18 | $21 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $31 | $33 | $39 | $43 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $117 | $111 | $96 | $91 |
| Liabilities | – | – | – | – |
| Payables | $3 | $5 | $3 | $6 |
| Short-Term Debt | $1 | $1 | $5 | $5 |
| Tax Payable | $0 | $1 | $0 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $4 | $3 | $3 |
| Total Curr. Liab. | $11 | $11 | $12 | $15 |
| LT Debt | $2 | $6 | $6 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $32 | $47 | $25 | $34 |
| Total NC Liab. | $34 | $53 | $31 | $40 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $3 | $4 | $4 |
| Total Liabilities | $45 | $64 | $43 | $54 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$113 | -$127 | -$121 | -$138 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $173 | $173 | $173 | $173 |
| Total Equity | $62 | $48 | $54 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $107 | $111 | $96 | $91 |
| Net Debt | -$23 | -$15 | -$0 | $3 |